Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study (Q38421550)
Jump to navigation
Jump to search
scientific article published on 30 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study |
scientific article published on 30 October 2014 |
Statements
1 reference
Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study (English)
1 reference
Mamitaro Ohtsuki
1 reference
Akimichi Morita
1 reference
Masatoshi Abe
1 reference
Hidetoshi Takahashi
1 reference
Noriko Seko
1 reference
Alexander Karpov
1 reference
Tomohiro Shima
1 reference
Charis Papavassilis
1 reference
Hidemi Nakagawa
1 reference
ERASURE Study Japanese subgroup
1 reference
30 October 2014
1 reference
1 reference
41
1 reference
12
1 reference
1039-1046
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference